137 related articles for article (PubMed ID: 22975754)
1. A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study.
Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T;
Ann Rheum Dis; 2013 Feb; 72(2):310-2. PubMed ID: 22975754
[No Abstract] [Full Text] [Related]
2. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.
Yazici Y; Yazici H
Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140
[No Abstract] [Full Text] [Related]
3. COMET's path, and the new biologicals in rheumatoid arthritis.
Kremer JM
Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
[No Abstract] [Full Text] [Related]
4. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
van der Heijde D; Klareskog L
Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
[No Abstract] [Full Text] [Related]
5. [Therapy of rheumatoid arthritis with etanercept].
Lamprecht P; Nitschmann S
Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
[No Abstract] [Full Text] [Related]
6. Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study.
Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T
J Rheumatol; 2011 Aug; 38(8):1585-92. PubMed ID: 21572151
[TBL] [Abstract][Full Text] [Related]
7. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al.
Seitz M; Villiger PM
Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454
[No Abstract] [Full Text] [Related]
8. Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.
van der Heijde D; Landewé R; Klareskog L; Rodríguez-Valverde V; Settas L; Pedersen R; Fatenejad S
Arthritis Rheum; 2005 Jan; 52(1):49-60. PubMed ID: 15641062
[TBL] [Abstract][Full Text] [Related]
9. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
[TBL] [Abstract][Full Text] [Related]
10. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
Cutolo M
Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
[No Abstract] [Full Text] [Related]
11. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
Ferraccioli G
Reumatismo; 2005; 57(4 Suppl):17-21. PubMed ID: 16385351
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
[TBL] [Abstract][Full Text] [Related]
13. [Etanercept].
Kameda H
Nihon Rinsho; 2013 Jul; 71(7):1214-7. PubMed ID: 23961669
[TBL] [Abstract][Full Text] [Related]
14. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S
Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230
[TBL] [Abstract][Full Text] [Related]
15. Overlap of systemic sclerosis and rheumatoid arthritis.
Alkassab F
J Rheumatol; 2007 Jul; 34(7):1593-4. PubMed ID: 17611965
[No Abstract] [Full Text] [Related]
16. Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial.
Fleischmann R; Kavanaugh A; Smolen J
Rheumatology (Oxford); 2013 Mar; 52(3):409-10. PubMed ID: 23070312
[No Abstract] [Full Text] [Related]
17. Etanercept in rheumatoid arthritis.
Cook DA; Dimick JB; Gallagher DC
N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383273
[No Abstract] [Full Text] [Related]
18. Etanercept in rheumatoid arthritis.
Ferraccioli GF; Di Poi E
N Engl J Med; 1999 Jun; 340(25):2000-1. PubMed ID: 10383275
[No Abstract] [Full Text] [Related]
19. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
20. COMET results are not stellar.
James M; Cleland L
Lancet; 2008 Nov; 372(9652):1807-8; author reply 1808. PubMed ID: 19027480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
